Stay updated with breaking news from Akida Development Environment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BrainChip Holdings Ltd (OTCMKTS:BRCHF – Get Rating) was the recipient of a significant growth in short interest during the month of June. As of June 15th, there was short interest totalling 2,316,300 shares, a growth of 33.1% from the May 31st total of 1,739,800 shares. Based on an average daily volume of 202,200 shares, the […]
BrainChip Holdings Ltd (OTCMKTS:BRCHF – Get Rating) was the target of a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 1,511,000 shares, a decrease of 28.6% from the February 28th total of 2,116,300 shares. Based on an average daily volume of 202,300 shares, the […]
4 weeks ago Development progress of Akida Neural Processor technology, industry partnerships and leadership expansion among highlights of the past year SAN FRANCISCO–(BUSINESS WIRE)–BrainChip Holdings Ltd. (ASX: BRN), a leading provider of ultra-low power, high-performance AI technology, ended the 2020 calendar year having made significant strides in the development of its technology backed by the launch of its Early Access Program (EAP), availability of Akida™ evaluation boards, new partnerships, and expansion of its executive leadership and global facil...
BrainChip powering artificial nose BrainChip ‘s AI processor is powering NaNose (Nano Artificial Nose) which tests exhaled breath samples for COVID-19. Using the NaNose Medical sensor array to collect the data, and Akida to perform the diagnosis, can have a higher rate of reliability than current testing methods and poses less risk to medical professionals because no saliva or mucus samples are collected. COVID-19 is known to be spread through respiratory droplets, and more recently has been confirmed to be airborne. Because Akida’s “Edge AI” is a complete neural processor that does...